Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Invivo Therapeutics Holdings Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Invivo Therapeutics Holdings Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Foose Brice | 10% Owner | 0 | Feb 7, 2024 | 0 |
| Marshak Daniel R | Director | – | Nov 21, 2022 | 0 |
| Rosenthal Bob | Director | – | Nov 21, 2022 | 0 |
| Merrifield C Ann | Director | – | Nov 21, 2022 | 0 |
| Christopher Richard | Chief Financial Officer | – | Nov 21, 2022 | 0 |
| Roberts Richard John | Director | – | Nov 21, 2022 | 0 |
| Morrison Christina | Director | – | Nov 21, 2022 | 0 |
| Toselli Richard M. | CEO and CMO | 6,201 | Nov 21, 2022 | 0 |
| Hamel Heather | Chief Legal Officer and GC | – | Nov 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 (view filing)2:12 PM ET | Feb 5-6, 2023 | 367 days | Foose Brice10% Owner | SSaleInVivo Therapeutics Holdings Corp | −330.0K | $0.3728 | −$123.0K | −100.0%0 after | Amended11 lots |